In patients with T2D, the risks for gastroesophageal reflux disease and related complications are greater with GLP-1 RA treatment than with SGLT2 inhibitor therapy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1s-increase-gerd-risk-over-sglt2-inhibitors-t2d-2025a1000q0h?src=rss
Author :
Publish date : 2025-09-29 12:16:00
Copyright for syndicated content belongs to the linked Source.